Alibaba Health Information Technology Limited (0241.HK)

HKSE · Healthcare · Pharmaceutical Retailers
2.62 HKD-2.24%As of 2026-11-22 · HKD
Last session low 2.56 HKDLast session high 2.67 HKD
52-week low 2.56 HKD52-week high 7.91 HKD
Market cap (USD)
$5.40B
Sector
Healthcare
P/E (TTM)
20.1x
Dividend yield
2.63%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in HKD.

IndicatorValueReading
RSI (14)32.9In the neutral range (30 to 70)
MACD (12, 26, 9)-0.05Below its signal line (-0.01); histogram -0.04
Bollinger %B (20, 2)1%Inside the bands (2.61 to 3.16)
SMA 202.89Price is 9.5% below
SMA 502.89Price is 9.5% below
SMA 2003.71Price is 29.5% below
ATR (20)3.82% of priceAverage true range per day
52-week position1%In the lower part of the 2.56 to 7.91 range

About Alibaba Health Information Technology Limited

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in the People's Republic of China.

Latest fiscal yearEnded 2026-03-31: revenue of 34.26B CNY and an operating margin of 5.5%.

More in Pharmaceutical Retailers and Healthcare